Related Experiment Video
Updated: Jun 17, 2026
07:30
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cognitive function and antihypertensive treatment in the elderly: a 6-year follow-up study
Esther Paran1, Ofra Anson, David T Lowenthal
1Hypertension Unit, Soroka University Medical Center, Beer-Sheva, Israel. paran@bgu.ac.il
American Journal of Therapeutics
|December 19, 2009
Summary
Calcium channel blockers (CCB) improved cognitive function and survival in the elderly. Other antihypertensive drugs showed mixed results, while statins had no cognitive effect.
Area of Science:
- Gerontology
- Cardiology
- Neurology
Background:
- Antihypertensive and statin treatments reduce cardiovascular disease risks in the elderly.
- The impact of these treatments on cognitive function in older adults remains unclear.
Purpose of the Study:
- To investigate the effects of antihypertensive treatments and statins on the cognitive functions of elderly individuals.
- To evaluate selective survival based on blood pressure changes, drug usage, and cognitive performance.
Main Methods:
- A longitudinal study involving 518 elderly individuals, with 318 re-examined after six years.
- Assessment of blood pressure, antihypertensive drug treatment (beta blockers, ACE inhibitors, CCB), statin use, and cognitive functions (MMSE, memory, concentration).
Main Results:
- Beta blocker treatment was linked to increased survival but also cognitive decline.
- ACE inhibitor treatment was associated with memory decline.
- Calcium channel blocker (CCB) treatment improved MMSE scores, memory, and concentration.
- Statin treatment showed no significant effect on cognitive functions.
- Low rates of blood pressure normalization were observed despite consistent antihypertensive regimens.
Conclusions:
- Calcium channel blockers (CCB) appear to be the most beneficial option for managing blood pressure in the elderly, potentially improving cognitive function without negatively impacting survival.
- Further research is needed to optimize antihypertensive strategies for cognitive health in aging populations.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...